CRIZANLIZUMAB vs CRIZOTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CRIZANLIZUMAB vs CRIZOTINIB: Safety Overview
| Metric | CRIZANLIZUMAB | CRIZOTINIB |
|---|---|---|
| Total FAERS Reports | 126 | 9,948 |
| Deaths Reported | 16 | 3,173 |
| Death Rate | 12.7% | 31.9% |
| Hospitalizations | 65 | 2,520 |
| Average Patient Age | 28.3 yrs | 58.5 yrs |
| % Female Patients | 53.5% | 55.2% |
| FDA Approval Date | N/A | Aug 26, 2011 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Pfizer Laboratories Div Pfizer Inc |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |